These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3098768)

  • 1. Calcium antagonists and the kidney.
    Loutzenhiser R; Epstein M
    Hosp Pract (Off Ed); 1987 Jan; 22(1):63-76. PubMed ID: 3098768
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists and the kidney.
    Chellingsworth M; Kendall MJ
    J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology of calcium antagonists].
    Ferrari M; Padrini R; Piovan D; Bova S; Cargnelli G
    Cardiologia; 1985 Feb; 30 Suppl 2():7-14. PubMed ID: 3830398
    [No Abstract]   [Full Text] [Related]  

  • 6. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renal effects of calcium antagonists].
    Rodicio Díaz JL
    Rev Clin Esp; 1990 Feb; 186(3):105-7. PubMed ID: 2356347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].
    Högestätt ED; Andersson KE
    Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The advantages of treatment with calcium blockers in arterial hypertension: a hope or a reality?].
    Dorobanţu M; Gherasim L
    Med Interna; 1993; 45(1-2):24-34. PubMed ID: 8081688
    [No Abstract]   [Full Text] [Related]  

  • 11. [From calcium antagonists to calcium antagonism].
    Ferrari R; Visioli O
    Cardiologia; 1985 Jan; 30(1):15-20. PubMed ID: 3896491
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium antagonists and vascular smooth muscle.
    Flaim SF
    Prog Clin Biol Res; 1986; 219():311-52. PubMed ID: 3786324
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modulation of electrical and contractile responses of the isolated abdominal aorta in hyperholesterinemia and after treatment with calcium antagonists].
    Liashenko VP; Pasichnichenko OM
    Fiziol Zh (1994); 2005; 51(2):73-80. PubMed ID: 15943234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of calcium entry blockers.
    Godfraind T
    Fed Proc; 1981 Dec; 40(14):2866-71. PubMed ID: 7308497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and excitation of the vascular muscle membrane.
    Hermsmeyer K; Kuthe C
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Voltage-dependent Ca2+ channels as targets for novel therapeutic drugs].
    Nagano T; Adach-Akahane S
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1013-22. PubMed ID: 10771667
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
    Greven J
    Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.